这是医业观察的第2115-5期文章
来源:360Dx、体外诊断观察翻译整理
DermTech是一家位于美国加利福尼亚州拉霍亚市的分子基因组学公司,专注于开发和销售用于诊断皮肤癌和相关疾病的非侵入性诊断测试。该公司利用其专有的qPCR检测方法,对非侵入性皮肤样本进行活检,...查看全文
$DermTech(DMTK)$ 8-K Current report, item 3.01 Accession Number: 0001651944-24-000063 Act: 34 Size: 147 KB 网页链接
$DermTech(DMTK)$ 8-K Current report, items 1.03, 2.05, 5.02, 8.01, and 9.01 Accession Number: 0001651944-24-000060 Act: 34 Size: 191 KB 网页链接
$DermTech(DMTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001651944-24-000055 Size: 4 KB 网页链接
$DermTech(DMTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001651944-24-000053 Size: 6 KB 网页链接
$DermTech(DMTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001651944-24-000051 Size: 8 KB 网页链接
$DermTech(DMTK)$ 8-K Current report, items 2.04 and 8.01 Accession Number: 0001651944-24-000049 Act: 34 Size: 148 KB 网页链接
$DermTech(DMTK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001651944-24-000047 Act: 34 Size: 4 MB 网页链接
$DermTech(DMTK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001651944-24-000044 Act: 34 Size: 251 KB 网页链接
$DermTech(DMTK)$ 8-K Current report, item 2.04 Accession Number: 0001651944-24-000039 Act: 34 Size: 149 KB 网页链接
$DermTech(DMTK)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-053184 Act: 34 Size: 175 KB 网页链接